Showing posts with label Protein. Show all posts
Showing posts with label Protein. Show all posts

Tuesday, 30 July 2013

Protein moulds RNA to ensure that activating factors can hold on to it

Main Category: Genetics
Article Date: 30 Jul 2013 - 0:00 PDT Current ratings for:
Protein moulds RNA to ensure that activating factors can hold on to it
not yet ratednot yet rated

X chromosomes are very special genetic material. They differ in number between men and women. To achieve equality between sexes, one out of two X chromosomes in women is silenced. In flies, the opposite happens: in male flies, the only available X chromosome is highly activated, to compensate for the absence of the second X-chromosome. Researchers from the Max Planck Institute of Immunobiology and Epigenetics (MPI-IE) in Freiburg have now shown how the RNA molecules and proteins involved in the activation find and stick to each other. Similar to a monkey that grabs a liana with hands and feet, one of the proteins holds on to the RNA. Then it moulds the molecular liana with its hands and thus generates a dynamic RNA - protein meeting place.

Just a few years ago, they were assumed to be genetic trash: DNA sequences that are not translated into proteins. But this has rapidly changed during the last years. Nowadays, it is widely known among scientists that much of the DNA is transcribed into RNA that, in turn, can act as gene regulator and structural element. Also in the regulation of sex chromosomes, RNA plays a central role. In both female humans and male flies one X chromosome is covered by a protein-RNA complex. In humans, this leads to chromosome silencing, while in flies it results in a double activation of the chromosome. Misregulation is lethal. Although known for many years, the interaction between the central proteins and the distinct role of the RNA strand was unclear.

Asifa Akhtar of the MPI-IE and her team now unravelled the function of the RNA and the interaction of the proteins. The protein MLE that is known to be a central player in X chromosome activation binds to the RNA in a very special manner. Like a monkey that grabs a liana with hands and feet, the protein grabs the RNA in two different ways. While one site is a simple anchor (the feet), the other (the hands) changes the form of the RNA. "The protein MLE moulds the RNA strand. This allows MLE to bind the RNA in a dynamic manner", says Asifa Akhtar, head of the study. Like one monkey helping the other to catch the liana MLE could thus help other proteins to grab the RNA strand. Thus, the whole X chromosome can be covered by the RNA-protein complex.

During his PhD work, first author Ibrahim Ilik investigated why MLE was found at the same places on the X chromosome but did not directly interact with other proteins. "The biochemical and the biological results seemed to point in different directions in the beginning", says Ilik. "But when we realised that the proteins bind highly specifically to certain regions of the very long RNA, this was a very exciting moment."

The researchers also found that individual mutations in the RNA hardly harm the protein-RNA binding. Only multiple mutations lead to a non-functional RNA and thus to lethality of male flies. "The system is very robust for evolutionary influences. This shows how important it is for the survival of the animals. In this, RNA could provide the necessary plasticity", says Akhtar. The scientists now want to explore the evolutionary conservation of the RNA-protein system and its equivalent in mammals.

Scientists at the Max Planck Institute of Immunobiology and Epigenetics (MPI-IE) in Freiburg investigate the development of the immune system over the course of evolution and during lifetime. They analyse genes and molecules that are important for immune cells maturation and activation. Researchers in the field of epigenetics investigate the inheritance of traits that are not caused by changes in the DNA sequence. Epigenetic research is expected to lead to a better understanding of many complex diseases, such as cancer and metabolic disorders.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our genetics section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Max-Planck-Gesellschaft. "Protein moulds RNA to ensure that activating factors can hold on to it." Medical News Today. MediLexicon, Intl., 30 Jul. 2013. Web.
30 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Protein moulds RNA to ensure that activating factors can hold on to it'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Sunday, 14 July 2013

New Source Of Powerful Immunity Protein Reported By Researchers

Main Category: Immune System / Vaccines
Also Included In: Infectious Diseases / Bacteria / Viruses
Article Date: 13 Jul 2013 - 0:00 PDT Current ratings for:
New Source Of Powerful Immunity Protein Reported By Researchers
not yet ratednot yet rated

Researchers at UT Southwestern Medical Center report the identification of a new cellular source for an important disease-fighting protein used in the body's earliest response to infection.

The protein interferon-gamma (IFN-?) keeps viruses from replicating and stimulates the immune system to produce other disease-fighting agents. Neutrophils, the newly identified cellular source of the protein, are the major component of the pus that forms around injured tissue.

The researchers also report that the neutrophils appear to produce IFN-? through a new cellular pathway independent of Toll-like receptors (TLRs): the body's early warning system for invasion by pathogens. This finding indicates that mammals might possess a second early-alert system - the sort of built-in redundancy engineers would envy, said Dr. Felix Yarovinsky, assistant professor of immunology and senior author of the study published online in the Proceedings of the National Academy of Sciences in June.

"We believe our mouse study provides strong evidence that neutrophils, white blood cells created in the bone marrow, produce significant amounts of IFN-? in response to disease," Dr. Yarovinsky said. "The finding of a new and essential cellular source for IFN-? challenges a long-held belief in the field and is significant because neutrophils are the most common kind of white blood cell."

Two pathogens were used in this study: the parasite Toxoplasma gondii - which can cause brain damage in humans and other mammals that have compromised immune systems - and a type of bacterium that causes gastroenteritis, Salmonella typhimurium.

Innate immunity is the body's first line of defense against pathogens, including those that it has never before encountered. Adaptive immunity is the secondary system that battles pathogens to which the body has previously been exposed and to which it has developed antibodies.

Textbooks list natural killer (NK) cells and T cells as the body's significant sources of IFN-?. Although large numbers of neutrophils have long been observed to congregate at the site of a new infection, they were commonly thought to be first responders or foot soldiers rather than generals in the battle against disease, as this study indicates they are, Dr. Yarovinsky explained.

About 20 years ago, there were clinical reports in humans and animals suggesting that neutrophils might produce IFN-?, but the idea was largely ignored by the scientific community until the last decade, he said.

Since then, studies at UT Southwestern and elsewhere have found that mice lacking NK and T cells, and therefore expected to be unable to produce IFN-?, somehow continued to withstand infections better than mice genetically unable to make any IFN-?. These observations suggested the possibility of an unknown source of the protein, he explained.

In a series of experiments, the UT Southwestern researchers identified neutrophils as the major source of IFN-? in mice lacking NK and T cells. "Based on what we know about neutrophils, their large numbers and rapid deployment to the site of infection should provide an important means of very early, robust, and rapid elimination of disease-causing agents," the researchers wrote. Although neutrophil-derived IFN-? alone is insufficient to achieve complete host protection, the protein significantly extended the survival of mice in this study, Dr. Yarovinsky said.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our immune system / vaccines section for the latest news on this subject.

Others involved include first author Carolyn Sturge, a graduate student of immunology; former research assistant Alicia Benson; research assistant II Megan Raetz; graduate student Cara L. Wilhelm; Dr. Julie Mirpuri, assistant professor of pediatrics; and Cancer Immunobiology Center Director Dr. Ellen Vitetta, professor of immunology and of microbiology.

Funding was provided by the National Institutes of Health and the Burroughs Wellcome Foundation. UT Southwestern Medical Center

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

UT Southwestern Medical Center. "New Source Of Powerful Immunity Protein Reported By Researchers." Medical News Today. MediLexicon, Intl., 13 Jul. 2013. Web.
14 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'New Source Of Powerful Immunity Protein Reported By Researchers'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Researchers Discover A Role For A Protein That Has Implications For Treatment Of Cancer And Heart Disease

Main Category: Cancer / Oncology
Also Included In: Heart Disease
Article Date: 14 Jul 2013 - 0:00 PDT Current ratings for:
Researchers Discover A Role For A Protein That Has Implications For Treatment Of Cancer And Heart Disease
not yet ratednot yet rated

St. Jude Children's Research Hospital scientists have discovered that a protein used by cancer cells to evade death also plays a vital role in heart health. This dual role complicates efforts to develop cancer drugs that target the protein, but may lead to new therapies for heart muscle damage. The research appeared in a recent edition of the scientific journal Genes & Development.

The protein, MCL1, is currently the focus of widespread cancer drug development efforts. MCL1 is best known as an inhibitor of death via the cell's suicide pathway in a process called apoptosis. The protein is elevated in a variety of cancers, and a number of MCL1 inhibitors are in the cancer drug development pipeline worldwide. The protein has also been linked to drug resistance in cancer patients. Until now, however, MCL1's role in heart muscle cells was unclear.

"Our study shows that MCL1 is required for normal cardiac function and that the protein may be critical in protecting the heart from apoptosis," said Joseph Opferman, Ph.D., an associate member of the St. Jude Department of Biochemistry and the paper's corresponding author. Unlike skin or blood cells, heart muscle cells cannot be replaced, so even a small loss through apoptosis can be devastating. In this study, knocking out MCL1 in mice led to death from cardiomyopathy within weeks.

"These findings suggest that cancer-related drug development efforts should focus on reducing MCL1 expression in target cells rather than eliminating the protein's function completely," Opferman said.

The results also have implications for treating heart muscle damage following heart attacks or other insults. While limiting MCL1 in cancer cells might aid in destroying them, providing higher levels of the protein in heart muscle cells might benefit a patient recovering from a heart attack or other heart damage. "These findings have broad implications for human health," Opferman said.

MCL1 belongs to a protein family involved in regulating apoptosis. The body uses apoptosis to rid itself of damaged, dangerous or unneeded cells. MCL1 prevents apoptosis by blocking the activity of other members of the same protein family that promote the process.

This research builds on previous work from Opferman's laboratory that identified a second form of MCL1. That form works inside rather than outside the mitochondria and helps to produce the chemical energy that fuels cells. Mitochondria are specialized structures inside cells that serve as their power plants.

The latest results suggest both forms of MCL1 are necessary for normal heart function, said the paper's first author Xi Wang, a University of Tennessee Health Science Center graduate student working in Opferman's laboratory.

When investigators knocked out the mouse version of the human MCL1 gene in the heart and skeletal muscle of both embryonic and adult mice, the animals rapidly developed lethal cardiomyopathy. Without MCL1, researchers found that muscle fiber in heart muscle cells was replaced by fibrous tissue, and the pumping ability of the animals' hearts diminished. Loss of MCL1 was also associated with a rise in apoptosis sufficient to cause fatal heart muscle weakness.

To better understand MCL1's role in normal heart function, researchers blocked apoptosis by deleting genes for the proteins Bak and Bax as well as MCL1. Bak and Bax promote apoptosis. Knocking out all three genes restored normal heart function in the mice. The animals lived longer, but mitochondria in the heart muscle did not look or function normally. These results suggest that normal heart function requires both forms of MCL1. "The question is whether, with time, you would see deleterious effects from the loss of MCL1 separate from apoptosis," Opferman said.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our cancer / oncology section for the latest news on this subject.

The other authors are Madhavi Bathina, John Lynch, Brian Koss, Christopher Calabrese, Sharon Frase, John Schuetz and Jerold Rehg, all of St. Jude.

The research was funded in part by a grant (HL102175) from the National Institutes of Health (NIH), a grant (CA021765) from the National Cancer Institute (NCI) at the NIH, the National Cancer Society and ALSAC.

St. Jude Children's Research Hospital

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

St. Jude Children\'s Research Hospital. "Researchers Discover A Role For A Protein That Has Implications For Treatment Of Cancer And Heart Disease." Medical News Today. MediLexicon, Intl., 14 Jul. 2013. Web.
14 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Researchers Discover A Role For A Protein That Has Implications For Treatment Of Cancer And Heart Disease'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here